In a recent study involving 537 patients, anti-inflammatory dose doxycycline achieved a statistically significant reduction in inflammatory lesion counts over placebo.
Research Observe, Classify Adverse Event Profiles for Pediatric Patients Treated With JAK Inhibitors
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
CG and Minoxidil Combination Therapy Shows Promise for AA
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Tackle Sports Dermatoses
Study Compares Dose Escalation with Biologics in Psoriasis